DoW Spinal Cord Injury, Clinical Trial Award

The FY26 Spinal Cord Injury Research Program (SCIRP) Clinical Trial Award (CTA) is a federal funding opportunity from the Defense Health Agency, managed by the Congressionally Directed Medical Research Programs (CDMRP). It supports clinical trials for spinal cord injury treatment and management, with an emphasis on rapid implementation and significant impact. The program provides roughly $9.76M to fund approximately two awards, each with a maximum performance period of four years. Applications are due by November 12, 2026, with a pre-application deadline of August 3, 2026. Eligibility extends to extramural and intramural U.S. Department of War organizations, including foreign, domestic, for-profit, and non-profit entities. A distinctive feature is the Early-Career Partnership Option, allowing two Principal Investigators (PIs), with at least one being an early-career investigator. All projects must include at least two SCI community partners for advice and consultation. The program focuses on four priority areas: Acute Injury Intervention, Secondary Health Effects, Psychosocial Well-Being, and Rehabilitation and Regeneration, requiring alignment with near-term programmatic goals.